array(3) {
["company_details"]=>
array(13) {
["name"]=>
string(21) "Elevance Health, Inc."
["slug"]=>
string(19) "410d3-us-anthem-inc"
["logo"]=>
string(84) "https://images.businessradar.com/linkedin_logos/450d7e13-9f07-44cd-ac18-ed35846aceac"
["description"]=>
string(580) "Fueled by our bold purpose to improve the health of humanity, we are transforming from a traditional health benefits organization into a lifetime trusted health partner.
Our nearly 100,000 associates serve more than 118 million people, at every stage of health. We address a full range of needs with an integrated whole health approach, powered by industry-leading capabilities and a digital platform for health.
We believe that improving health for everyone is possible. It begins by redefining health, reimagining the health system, and strengthening our communities."
["address_street"]=>
string(16) "220 Virginia Ave"
["address_place"]=>
string(12) "Indianapolis"
["address_region"]=>
string(7) "Indiana"
["founding_date"]=>
string(10) "1944-02-28"
["website_domain"]=>
string(18) "elevancehealth.com"
["website_url"]=>
string(30) "https://www.elevancehealth.com"
["industry_codes"]=>
array(2) {
[0]=>
string(29) "Accident and Health Insurance"
[1]=>
string(34) "Hospital and Medical Service Plans"
}
["employee_count"]=>
int(98200)
["article_count"]=>
int(548)
}
["articles"]=>
array(9) {
[0]=>
array(7) {
["title_en"]=>
string(123) "Elevance Health Reports Q1 2024 Financial Results: Improving Healthcare Services for Over 115 Million Consumers - News Sand"
["snippet_en"]=>
string(155) "Elevance Health (NYSE: ELV) has announced that they will be releasing their financial results for the first quarter of 2024 on April 18, 2024, at 6:00 a.m."
["url"]=>
string(132) "https://newssand.com/elevance-health-reports-q1-2024-financial-results-improving-healthcare-services-for-over-115-million-consumers/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/58200795-606a-4039-8897-229c22ca77dc"
["source"]=>
string(12) "newssand.com"
["publication_date"]=>
string(10) "2024-04-03"
["categories"]=>
array(2) {
[0]=>
string(31) "Financial Update/Profit Warning"
[1]=>
string(24) "Quarterly/Annual Figures"
}
}
[1]=>
array(7) {
["title_en"]=>
string(57) "Elevance Health posts $856M in profit in Q4 earnings beat"
["snippet_en"]=>
string(159) "UPDATED: 12:50 p.m. on Jan. 24 | Elevance Health beat the Street on both earnings and revenue for the fourth quarter of 2023, reporting $856 million in profit."
["url"]=>
string(90) "https://www.fiercehealthcare.com/payers/elevance-health-posts-856m-profit-q4-earnings-beat"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/9e07ae56-a966-4aff-9bb0-0d8046757795"
["source"]=>
string(20) "fiercehealthcare.com"
["publication_date"]=>
string(10) "2024-01-24"
["categories"]=>
array(2) {
[0]=>
string(31) "Financial Update/Profit Warning"
[1]=>
string(24) "Quarterly/Annual Figures"
}
}
[2]=>
array(7) {
["title_en"]=>
string(74) "Elevance Health (ELV) Beats EPS Expectations at $10.64 in Q1, Revenue Miss"
["snippet_en"]=>
string(123) "Elevance Health, Inc. (NYSE: ELV) showcased strategic advancements with operating revenue reaching $42.3 billion in the Q1."
["url"]=>
string(87) "https://tokenist.com/elevance-health-inc-elv-surpasses-eps-expectations-at-10-64-in-q1/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/d41e2a12-0c06-4f53-bfab-6372dae20c7e"
["source"]=>
string(12) "tokenist.com"
["publication_date"]=>
string(10) "2024-01-04"
["categories"]=>
array(2) {
[0]=>
string(31) "Financial Update/Profit Warning"
[1]=>
string(24) "Quarterly/Annual Figures"
}
}
[3]=>
array(7) {
["title_en"]=>
string(47) "Jim Beam column:Blue Cross sale still unpopular"
["snippet_en"]=>
string(238) "Some changes have been made to the plan to sell Blue Cross and Blue Shield of Louisiana to Elevance Health of Indianapolis. Officials with both companies say they are optimistic the sale will be finalized during the first quarter of 2024."
["url"]=>
string(88) "https://www.americanpress.com/2023/12/20/jim-beam-columnblue-cross-sale-still-unpopular/"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/1546ad08-d99f-4a80-bdae-ecf5be31c25d"
["source"]=>
string(17) "americanpress.com"
["publication_date"]=>
string(10) "2023-12-20"
["categories"]=>
array(3) {
[0]=>
string(31) "Financial Update/Profit Warning"
[1]=>
string(10) "Divestment"
[2]=>
string(15) "Blogs & Columns"
}
}
[4]=>
array(7) {
["title_en"]=>
string(96) "Blue Cross policyholders aren’t entitled to profit from the pending sale, but this group might"
["snippet_en"]=>
string(182) "While Blue Cross and Blue Shield of Louisiana covers some 1.9 million Louisiana residents, only about 92,000 will get to vote on the potential sale of the company to Elevance Health."
["url"]=>
string(119) "https://www.businessreport.com/business/blue-cross-policyholders-wont-profit-from-the-pending-sale-but-this-group-might"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/d59b2783-ea46-4c33-9e07-b73b9805186f"
["source"]=>
string(18) "businessreport.com"
["publication_date"]=>
string(10) "2023-09-15"
["categories"]=>
array(2) {
[0]=>
string(31) "Financial Update/Profit Warning"
[1]=>
string(10) "Divestment"
}
}
[5]=>
array(7) {
["title_en"]=>
string(51) "Elevance Health Reports Second Quarter 2023 Results"
["snippet_en"]=>
string(184) "Second quarter GAAP net income was $7.79 per share, including net negative adjustment items of $1.25 per share. Adjusted net income was $9.04* per share.Operating revenue grew 12.7%..."
["url"]=>
string(87) "https://www.wicz.com/story/49214349/elevance-health-reports-second-quarter-2023-results"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/146d257a-390b-4828-a30c-1403bae2d14b"
["source"]=>
string(8) "wicz.com"
["publication_date"]=>
string(10) "2023-07-28"
["categories"]=>
array(3) {
[0]=>
string(31) "Financial Update/Profit Warning"
[1]=>
string(12) "Stock Market"
[2]=>
string(24) "Quarterly/Annual Figures"
}
}
[6]=>
array(7) {
["title_en"]=>
string(64) "Elevance Health Inc. (NYSE:ELV) Q2 2023 Earnings Call Transcript"
["snippet_en"]=>
string(293) "Elevance Health Inc. (NYSE:ELV) Q2 2023 Earnings Call Transcript July 19, 2023 Elevance Health Inc. beats earnings expectations. Reported EPS is $9.04, expectations were $8.8. Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Elevance Health Second Quarter Earnings"
["url"]=>
string(77) "https://hk.finance.yahoo.com/news/elevance-health-inc-nyse-elv-112841666.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/d81adab3-f64c-4339-b006-5e1cb01d51c0"
["source"]=>
string(9) "yahoo.com"
["publication_date"]=>
string(10) "2023-07-22"
["categories"]=>
array(2) {
[0]=>
string(31) "Financial Update/Profit Warning"
[1]=>
string(24) "Quarterly/Annual Figures"
}
}
[7]=>
array(7) {
["title_en"]=>
string(65) "Elevance Health stock surges on earnings beat, full-year forecast"
["snippet_en"]=>
string(223) "Shares of Elevance Health jumped after topping its second-quarter earnings expectations and issuing a strong full-year outlook. Yahoo Finance Live take a look into the stock action surrounding the health insurance provider."
["url"]=>
string(78) "https://sg.news.yahoo.com/elevance-health-stock-surges-earnings-141635617.html"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/aee9b968-aef4-48d9-869b-3df0f9b4c60c"
["source"]=>
string(9) "yahoo.com"
["publication_date"]=>
string(10) "2023-07-19"
["categories"]=>
array(5) {
[0]=>
string(31) "Financial Update/Profit Warning"
[1]=>
string(14) "Issuing Shares"
[2]=>
string(24) "Quarterly/Annual Figures"
[3]=>
string(24) "Stock Research & Ratings"
[4]=>
string(12) "Stock Market"
}
}
[8]=>
array(7) {
["title_en"]=>
string(51) "Elevance Health Reports Second Quarter 2023 Results"
["snippet_en"]=>
string(203) "INDIANAPOLIS--(BUSINESS WIRE)--Elevance Health, Inc. (NYSE: ELV) reported second quarter 2023 results reflecting strong financial performance, including double-digit growth in revenue, operating earnings"
["url"]=>
string(121) "https://www.finanznachrichten.de/nachrichten-2023-07/59611429-elevance-health-reports-second-quarter-2023-results-004.htm"
["image_url"]=>
string(78) "https://images.businessradar.com/articles/027817d4-0709-4823-87e3-2d99ad48f012"
["source"]=>
string(20) "finanznachrichten.de"
["publication_date"]=>
string(10) "2023-07-19"
["categories"]=>
array(2) {
[0]=>
string(31) "Financial Update/Profit Warning"
[1]=>
string(24) "Quarterly/Annual Figures"
}
}
}
["category_annotations"]=>
array(30) {
[0]=>
array(2) {
["name"]=>
string(12) "Stock Market"
["count"]=>
int(96)
}
[1]=>
array(2) {
["name"]=>
string(24) "Quarterly/Annual Figures"
["count"]=>
int(61)
}
[2]=>
array(2) {
["name"]=>
string(11) "Acquisition"
["count"]=>
int(55)
}
[3]=>
array(2) {
["name"]=>
string(24) "Stock Research & Ratings"
["count"]=>
int(30)
}
[4]=>
array(2) {
["name"]=>
string(31) "Financial Update/Profit Warning"
["count"]=>
int(28)
}
[5]=>
array(2) {
["name"]=>
string(24) "Access and affordability"
["count"]=>
int(23)
}
[6]=>
array(2) {
["name"]=>
string(18) "General Investment"
["count"]=>
int(23)
}
[7]=>
array(2) {
["name"]=>
string(5) "Legal"
["count"]=>
int(21)
}
[8]=>
array(2) {
["name"]=>
string(12) "Board Change"
["count"]=>
int(20)
}
[9]=>
array(2) {
["name"]=>
string(10) "Divestment"
["count"]=>
int(15)
}
[10]=>
array(2) {
["name"]=>
string(15) "Market Movement"
["count"]=>
int(15)
}
[11]=>
array(2) {
["name"]=>
string(22) "Purchasing contracting"
["count"]=>
int(13)
}
[12]=>
array(2) {
["name"]=>
string(14) "Issuing Shares"
["count"]=>
int(12)
}
[13]=>
array(2) {
["name"]=>
string(13) "Collaboration"
["count"]=>
int(11)
}
[14]=>
array(2) {
["name"]=>
string(16) "Customer Welfare"
["count"]=>
int(10)
}
[15]=>
array(2) {
["name"]=>
string(11) "Regulations"
["count"]=>
int(10)
}
[16]=>
array(2) {
["name"]=>
string(13) "Credit Rating"
["count"]=>
int(10)
}
[17]=>
array(2) {
["name"]=>
string(14) "Product Launch"
["count"]=>
int(9)
}
[18]=>
array(2) {
["name"]=>
string(8) "Epidemic"
["count"]=>
int(9)
}
[19]=>
array(2) {
["name"]=>
string(21) "Competitive Behaviour"
["count"]=>
int(9)
}
[20]=>
array(2) {
["name"]=>
string(18) "Expansion & Growth"
["count"]=>
int(9)
}
[21]=>
array(2) {
["name"]=>
string(11) "Name Change"
["count"]=>
int(8)
}
[22]=>
array(2) {
["name"]=>
string(24) "Employee Health & Safety"
["count"]=>
int(8)
}
[23]=>
array(2) {
["name"]=>
string(15) "Blogs & Columns"
["count"]=>
int(7)
}
[24]=>
array(2) {
["name"]=>
string(15) "Deals & Tenders"
["count"]=>
int(7)
}
[25]=>
array(2) {
["name"]=>
string(10) "Litigation"
["count"]=>
int(7)
}
[26]=>
array(2) {
["name"]=>
string(19) "Under Investigation"
["count"]=>
int(7)
}
[27]=>
array(2) {
["name"]=>
string(7) "Opening"
["count"]=>
int(6)
}
[28]=>
array(2) {
["name"]=>
string(15) "Business Ethics"
["count"]=>
int(6)
}
[29]=>
array(2) {
["name"]=>
string(5) "Award"
["count"]=>
int(6)
}
}
}
410d3-us-anthem-inc
Elevance Health, Inc.
Location
Indiana
Founded
1944-02-28
Website
https://www.elevancehealth.com
Articles
548 Articles
Category
Accident and Health Insurance
Hospital and Medical Service Plans
Description
Fueled by our bold purpose to improve the health of humanity, we are transforming from a traditional health benefits organization into a lifetime trusted health partner.
Our nearly 100,000 associates serve more than 118 million people, at every stage of health. We address a full range of needs with an integrated whole health approach, powered by industry-leading capabilities and a digital platform for health.
We believe that improving health for everyone is possible. It begins by redefining health, reimagining the health system, and strengthening our communities.
Elevance Health (NYSE: ELV) has announced that they will be releasing their financial results for the first quarter of 2024 on April 18, 2024, at 6:00 a.m.
UPDATED: 12:50 p.m. on Jan. 24 | Elevance Health beat the Street on both earnings and revenue for the fourth quarter of 2023, reporting $856 million in profit.
Some changes have been made to the plan to sell Blue Cross and Blue Shield of Louisiana to Elevance Health of Indianapolis. Officials with both companies say they are optimistic the sale will be finalized during the first quarter of 2024.
While Blue Cross and Blue Shield of Louisiana covers some 1.9 million Louisiana residents, only about 92,000 will get to vote on the potential sale of the company to Elevance Health.
Second quarter GAAP net income was $7.79 per share, including net negative adjustment items of $1.25 per share. Adjusted net income was $9.04* per share.Operating revenue grew 12.7%...
Elevance Health Inc. (NYSE:ELV) Q2 2023 Earnings Call Transcript July 19, 2023 Elevance Health Inc. beats earnings expectations. Reported EPS is $9.04, expectations were $8.8. Operator: Ladies and gentlemen, thank you for standing by, and welcome to the Elevance Health Second Quarter Earnings
Shares of Elevance Health jumped after topping its second-quarter earnings expectations and issuing a strong full-year outlook. Yahoo Finance Live take a look into the stock action surrounding the health insurance provider.
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional
Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes.The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
